Lucentis | search
Click here to view Lucentis news from 60+ newspapers.
Bookmark or Share- About LUCENTIS for wAMDLUCENTIS is a prescription medicine that is designed to block vascular endothelial (VASS‐cue‐ler end‐oh‐THEEL‐e‐ull) growth factor, or VEGF (vej‐EFF), from inside the eye. It was approved in 2006 to treat wet age-related macular degeneration (wet AMD).
- Side Effects of LUCENTIS® (ranibizumab) for RVOLUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious eye infections. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.
- Possible Side Effects of LUCENTIS® (ranibizumab) for wAMDLUCENTIS is contraindicated in patients with ocular or periocular infections or known hypersensitivity to ranibizumab or any of the excipients in LUCENTIS. Hypersensitivity reactions may manifest as severe intraocular inflammation.
- Clinical Trial Efficacy & Results for wAMD - lucentisLearn about LUCENTIS® (ranibizumab injection) clinical trial results for wet AMD patients here. See full safety for more information.
- Wet AMD Treatment Option | LUCENTIS® (ranibizumab)LUCENTIS is a prescription medicine for the treatment of wet age-related macular degeneration, or wet AMD. Explore this site to learn more about wet AMD, treatment, and what you may expect on your journey with LUCENTIS.
More
